​
​

Candel Therapeutics (CADL) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Candel Therapeutics Revenue Highlights

00

Candel Therapeutics Revenue by Period

Candel Therapeutics Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31--
2021-12-31--
2020-12-31--
2019-12-31--

Candel Therapeutics generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Candel Therapeutics Revenue by Quarter

DateRevenueChange
2024-03-31--100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31--
2022-09-30--
2022-06-30--
2022-03-31--
2021-12-31--
2021-09-30--
2021-06-30--
2021-03-31--
2020-12-31--
2020-09-30--
2020-06-30--
2020-03-31--

Candel Therapeutics generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Candel Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ADAGAdagene--
MOLNMolecular Partners--
ANEBAnebulo Pharmaceuticals--
RZLTRezolute--
FBRXForte Biosciences--
ANTXAN2 Therapeutics--
PHVSPharvaris--
AVTEAerovate Therapeutics--
ACXPAcurx Pharmaceuticals--
OKYOOKYO Pharma--
TPSTTempest Therapeutics--
ACRVAcrivon Therapeutics--
PMVPPMV Pharmaceuticals--
MLYSMineralys Therapeutics--
MNPRMonopar Therapeutics--
CADLCandel Therapeutics--
ENOBRenovaro Biosciences--
INDPIndaptus Therapeutics--
PEPGPepGen--

CADL Revenue FAQ

What is Candel Therapeutics’s yearly revenue?

Candel Therapeutics's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $125K, representing an increase of 0% compared to 2021. CADL's yearly revenue for 2021 was $125K, representing an increase of 0% compared to 2020.

What is Candel Therapeutics’s quarterly revenue?

Candel Therapeutics's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $1.78M, a 100.00% increase from the previous quarter (Q3 2023), and a 5629.03% increase year-over-year (Q4 2022). CADL's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a -100.00% decrease year-over-year (Q3 2022).

What is Candel Therapeutics’s revenue growth rate?

Candel Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was -100.00%.